As rising numbers of people are living with the long-term impact of cancer, digital health is playing an increasingly important role in the monitoring and support of survivors and their caregivers. This article reviews current evidence, practice and developments, and identifies emerging issues and opportunities.
INTRODUCTION
Over 14 million people worldwide are diagnosed with cancer each year, and it is predicted that this will increase to more than 23 million by 2030 [1, 2] . Over the past 2 decades, life expectancy for those diagnosed with cancer has improved greatly due to advances in prevention, diagnosis and treatment [3, 4] . Consequently, increasing numbers of people are living longer with the consequences of cancer and its treatment, requiring on-going support involving complex coordination of care by primary and specialist care professionals [5] . However, over half of cancer survivors report unmet supportive care needs after cancer treatment, experiencing adverse late effects and on-going symptoms [6, 7] . This unmet need, coupled with increasing patient numbers, escalating costs and limited resource, has led to a surge in the development of digital health technologies to help monitor and support people health in supportive cancer care is a potential route to optimize the provision and coordination of services [5, 9] , overcome some barriers to on-going support and improve poorer outcomes for those living in remote and underserved areas [11, 12] , or as a lower cost alternative in which access to healthcare is not universal [13, 14] .
The implementation of digital health innovations in supportive cancer care is now only feasible due to rapid advances in technology, affordability and near ubiquitous internet access in some populations [15, 16] . Currently, over half the world's population have internet access, with coverage above 85% in Europe and North America [17] . Further, over 35% of the world's population have access to a smartphone, and this is expected to increase to over 40% in the next 3 years, although rates in many developed economies are much higher (e.g. 80% in the United Kingdom) [18] . However, although there are hundreds of supportive cancer-related apps on the market, there are real concerns about the lack of evidence on their efficacy, effectiveness, safety and privacy standards [19] .
The current article reviews current evidence, practice and developments on the role of digital health in supporting cancer patients and horizon scans emerging issues and opportunities. We focused on literature published in the past 18 months available through Google scholar and/ or PubMed using terms such as cancer/oncology, eHealth/digital health/mHealth/internet, symptom management/monitoring, supportive and followup care. Commercial chemotherapy-related apps were identified via Google Play and iTunes App Store. For clarity, we focus on four key domains in which digital health currently shows most promise in relation to supportive cancer care, but we recognize this is selective, and there may be other important digital innovations not detailed here.
SYMPTOM MANAGEMENT AND MONITORING
Perhaps the most prolific area of innovation is in the use of internet and/or smartphone-enabled technologies offering support to clinicians working in cancer care and symptom monitoring for cancer patients. Many available healthcare apps are multifunctional and potentially mutually beneficial, providing insightful symptom data via patient reported outcomes to assist clinicians' decision-making, while also acting as a useful tool for patients to monitor and self-manage their own symptoms [20] . Most publicly downloadable apps have not been tested in clinical trials and therefore have limited proven efficacy or effectiveness [19] . However, many are created and endorsed by clinicians offering similar functions to those developed within trials. A summary of these technologies, developed within the context of clinical trials, are included in Table 1 ]. Chemotherapy-related symptom monitoring (CSM) is a widely explored mobile health feature, which is unsurprising as delays in symptom reporting is recognized as being associated with increased hospital admissions, reduced quality of life [29] and even fatality [30] . Most publicly available mobile applications ( Appropriate application of digital health has the potential to deliver and enhance optimal, timely and patient-centred care, enabling greater independence and home-based cancer care. It may also offer opportunities to augment supportive care in which specialist expertise is required, or for groups of people and regions where supportive care is underprovided.
Many internet and smartphone-based applications are available on the market; however, empirical research on the preliminary phases and scientific evidence of their clinical efficacy and effectiveness in routine practice is currently lacking and is urgently required if they are to be adopted by patients and healthcare providers.
Researchers and cancer clinicians need be vigilant to technological developments to capitalize on the opportunities they offer. Patient, health professional and transdisciplinary involvement in development and testing is crucial to ensure digital health innovations are acceptable, efficacious and can be implemented in practice. ]. As technology develops, it is likely that wearables (smart electronic devices that can be worn, such as activity trackers, or possibly implanted, and exchange data via the internet) and the internet of things (IoT, a network of connected everyday devices, connected to the internet and exchanging data) will provide interesting avenues for the remote monitoring of symptoms, particularly for those cancer patients with complex comorbidities and social care needs [16] .
DECISION-MAKING AND INFORMATION SHARING
An important opportunity afforded by technological innovation is the routine use of video-conferencing by cancer Multi-Disciplinary Team (MDTs, also known as case conferences or tumour boards) meetings in which new patient cases are discussed and recommendations for treatments made [35] . In the United Kingdom and elsewhere, groups of cancer MDTs use this technology to discuss patient care, increase access to specialist knowledge, promote shared decision-making and reduce financial costs and inconvenience of travel [36] . Further, an ongoing pilot study by the charity Macmillan Cancer Support is developing a virtual MDT to enable multispecialist advice for patients with complex or severe chronic symptoms following cancer treatment, or specific patient groups (e.g. rare tumour types, childhood and adolescent cancers) [36, 37] . Video-conferencing has also been used to bring patients and their carers into the MDT meeting with the aim of improving shared decision-making [38] . However, a recent qualitative study found that although this approach had the potential to enhance team-based care, both patients and physicians expressed concerns about how the often-informal nature of video-conferencing may impact the patient-physician relationship [39 & ]. Digital health has the potential to facilitate enhanced information flow and improved patientcentred treatment decision-making [40] . It may offer better use of resources by making supportive care consultations more efficient and effective and provide the patient with more opportunity to discuss options with family and friends, consider competing demands and possible consequences [40, 41] . As a result, decisional support tools have been developed to assist patients in the decision-making process and increasingly have been adapted to a digital format. However, there is currently limited evidence in cancer that digital delivery is superior to, often cheaper, written alternatives or preferred by patients to face-to-face consultations [42] .
SURVIVORSHIP AND FOLLOW-UP CARE
As it is increasingly recognized that there is a need to better support people once their cancer treatment has ended, so health professionals have started to explore the role that technology can play in ensuring services are cost effective. Research investigating the application of health technologies during the survivorship phase has mostly focused on assessing the acceptability, feasibility and efficacy of online interventions to improve symptoms [ ], at least in the short-term. In addition, evidence from a recent study investigating the efficacy of a web-based tailored behavioural change intervention indicated it was associated with improved depression, fatigue and social and emotional functioning at 6-months. Although these effects were not sustained longer term (12- ], they also raise important issues that require careful consideration in future studies. In those where the technology replaced interaction with a health professional, the authors highlight the need to ensure sustained engagement with the intervention, as many survivors' interest waned and they either did not complete the intervention or they dropped out of the study [44
There is also a need to identify who is most likely to benefit from digital interventions and barriers to engagement [41] . Willems et al. [45 && ] explored this issue by undertaking a moderator analysis. At 6 months follow-up, they found their digital intervention brought about significant improvements in social functioning in men, fatigue in younger people (56 years) and depression in those treated with chemotherapy. At 12 months, only educational level moderated impact, with those with a lower level reporting lower social functioning.
A systematic review of qualitative studies exploring survivors' experiences of using digital interventions identified several important concerns (burden, human factor, slipping through the net) and drivers (convenience, independence, active and passive connection, reassurance, time-efficiency) to adoption that need to be addressed when designing survivorship technology-based symptom interventions in the future [54
&&
]. Further, the review identified a complex interplay between the convenience of digital home-based interventions, reliance upon instant access to clinical support and increased responsibility, and potential burden, placed upon the survivor [54 && ]. Haggerty et al. [52] highlights that when offered a preference between online or paper-based versions of an intervention, older people were more likely to opt for the latter. This means that online-only interventions may not reach all those who may benefit from them and supports the notion that 'one size may not fit all'.
Digital interventions that augment interaction with health professionals achieve sustained engagement [46 && ], whereas survivors' motivation can be reduced by a lack of health professional engagement [49] . This highlights the importance of taking account of both survivor and professional views in exploring how digital innovation will fit within clinical practice [40] .
PALLIATIVE AND END OF LIFE CARE
Increasingly researchers have begun to explore the role of digital health in supporting cancer patients at the end of life. Early systematic reviews found that most interventions focussed on a narrow range of supportive roles and activities such as information provision, care planning and symptom relief [55, 56] . A recent comprehensive review of the literature and market by Pinto et al. [57 && ] found 25 research article and 40 downloadable palliative care apps, although not all had a cancer-specific focus, the findings were relevant within a cancer context. Overall most current palliative care apps focus on patient-professional teleconsultation (n ¼ 15), but other roles include patient education and symptom management, information about clinical guidelines or drug administration aimed at palliative care professionals. Their review identified important strengths of digital solutions in palliative care including the facilitation of monitoring by a specialist teams, promotion of homecare, fewer home visits and less use of emergency services; however, weaknesses included frequent technical problems and reporting less comprehensive home visits. As with other domains discussed, few studies or apps on the market used validated instruments or presented evidence of efficacy [57 && ]. A recent RCT comparing weekly palliative care teleconsultations at home for patients with advanced cancer to standard hospital-based palliative care consultation found evidence of worse outcomes for those receiving the teleconsultation intervention, including increased levels of distress and anxiety [58] . The authors conclude this is because the intervention heightened attention on symptoms and suffering, and was inferior to the already good standard of the existing palliative care services available [58] . It may be that in some areas of cancer, particularly at the end of life, it is challenging for digital health to replace the quality of the human interaction. However, digital health may be able to complement usual care if used appropriately and sensitively. An emerging area of research that warrants further attention is the use of e-diaries at the end of life in cancer care [59] and comfort monitoring [60] , with the potential to provide palliative care professionals with invaluable information about the patients' needs and preferences which they can action in real-time. This may be an important area for future development particularly in regions where cancer patients have limited access to palliative care professionals [57 && ].
FUTURE OPPORTUNITIES FOR RESEARCH AND PRACTICE
Recently published research presents promising evidence on the role of digital health technologies in supportive cancer care; however, benefits of all technologies should not be assumed and require evaluation of efficacy and effectiveness [46 && ,53 && ,61]. This is important in relation to symptom monitoring, in which rigorous safety criteria need to be applied and adhered to, to ensure that life threatening complications are not missed or overlooked, and so the technology can be reasonably recommended by healthcare professionals and invested in by healthcare providers. RCT methodology is the gold standard for generating evidence of clinical efficacy; however, alternative research methods are available that also generate useful insights such as large-scale observational studies and analysis of high-quality routine data. Further we need to better understand how best to deploy digital interventions in clinical practice to ensure patient safety and improve patient outcomes during implementation [62] .
Issues of accessibility, preference and reach need greater consideration when developing digital innovations if inequalities in provision are to be avoided. There are wide variations in the accessibility of digital technology worldwide; however, less is known about cancer patient's access and preferences, or the sustainability of digital interventions with limited research suggesting higher uptake among younger and more affluent cancer survivors [63, 64] In future, innovations in predictive analytics, machine learning and artificial intelligence, particularly for use in stratified survivorship care, are likely to play an increasingly important role [61, 66] . The use of wearables and the IoT, incorporating passive monitoring, are also likely to be more feasible and less intrusive for application within supportive cancer care [16, 67] . These will require appropriate regulatory and legislative frameworks on sensitive data sharing and security to address public, patient and professional's concerns [16] .
CONCLUSION
Digital health innovations have the potential to have a positive impact on cancer survivors' clinical outcomes and on-going experience, by supporting a less disrupted life [54 && ]. Their adoption offers opportunities for optimizing use of resources, more personalized and anticipatory care with greater convenience and autonomy through self-management. However, despite high levels of activity in commercial sector, overall research evidence is preliminary, and more is needed to unpick the role that digital health can and should have in supporting cancer survivors and their caregivers.
